Genetic Variants of the Receptors for Thromboxane A2 and IL-4 in Atopic Dermatitis
- 1 April 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 292 (3) , 776-780
- https://doi.org/10.1006/bbrc.2002.6713
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor α chain gene: heterogeneity of genetic backgrounds on immunoglobulin E production in atopic eczema patientsClinical and Experimental Allergy, 2001
- Down-regulation of T Cell Activation following Inhibition of Dipeptidyl Peptidase IV/CD26 by the N-terminal Part of the Thromboxane A2 ReceptorJournal of Biological Chemistry, 2000
- Interleukin 4 receptor α chain polymorphism Gln551Arg is associated with adult atopic dermatitis in JapanBritish Journal of Dermatology, 2000
- Can we predict atopic disease using perinatal risk factors?Clinical and Experimental Allergy, 1998
- Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families.Journal of Medical Genetics, 1998
- The Association of Atopy with a Gain-of-Function Mutation in the α Subunit of the Interleukin-4 ReceptorNew England Journal of Medicine, 1997
- Association between genetic variants of mast-cell chymase and eczemaThe Lancet, 1996
- Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin‐1 in peripheral blood mononuclear cells from patients with atopic dermatitisClinical and Experimental Allergy, 1995
- Familial Background of Respiratory AtopyArchives of Dermatology, 1989
- Prostaglandins and ThromboxanesAnnual Review of Biochemistry, 1978